Clinical Trial Update: Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the efficacy and safety of SR58611 versus placebo and paroxetine in major depressive disorder; the document provides an update on th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)
• SR58611

Snippet

Sponsor: Sanofi | Conditions: Major Depressive Disorders | Phase 3 | Status: COMPLETED